Papa Murphy's Holdings, Inc. to Attend Investor Conferences in January
Jan 06, 2016 13:00 pm UTC| Business
VANCOUVER, Wash., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Papa Murphy’s Holdings, Inc. (Nasdaq:FRSH) today announced the Company will present at two upcoming investor conferences. On Tuesday, January 12, 2016, the Company...
AMAG Pharmaceuticals Announces $60 Million Share Repurchase Program
Jan 06, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that its Board of Directors has approved a share repurchase program under which AMAG may purchase up to $60...
Jan 06, 2016 13:00 pm UTC| Business
New Haven, CT, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat bacterial infections, announced the initiation of an international Phase 3...
BBCN Bancorp to Announce 2015 Fourth Quarter Financial Results on Monday, January 25, 2016
Jan 06, 2016 13:00 pm UTC| Business
LOS ANGELES, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BBCN Bancorp, Inc. (NASDAQ:BBCN) today announced that the company will issue its financial results for the 2015 fourth quarter and full year after the market closes on...
Pro Star Freight Systems, Inc. Completes Land Acquisition in Hammond, Indiana
Jan 06, 2016 13:00 pm UTC| Business
CHICAGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- HydroPhi Technologies, Inc. (OTC:HPTG) subsidiary Pro Star Freight Systems, Inc. (“Pro Star” or “Company”) announced today the purchase of land for the development of an...
Sonoco Announces Quarterly Conference Calls and Webcasts for 2016
Jan 06, 2016 13:00 pm UTC| Business
HARTSVILLE, S.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Sonoco (NYSE:SON), one of the largest diversified global packaging companies, will host its regular quarterly investor conference calls on the below dates and times. As...
Medgenics Licenses Novel GeneRide Gene Therapy Technology From Stanford University
Jan 06, 2016 13:00 pm UTC| Business
PHILADELPHIA, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), today announced the signing of a license with Stanford University providing exclusive rights to certain breakthrough gene therapy technologies...